lenalidomide
Not Tagged
['revlimid']
#ash2022 day two brought us updates on the use of fda-approved treatments, including a closer look on the length of revlimid maintenance therapy, and the clinical potential of a few investigational therapies for heavily pre-treated patients with #myeloma. 
Multiple Myeloma Research Foundation - Accelerating the development of next generation #myeloma treatments to extend patient’s lives, and lead to a cure.